On 2 October 2026, Bayzed Health Group Inc, a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange, published its Monthly Return for the period ended 30 September 2026. The filing shows a stable capital structure, with no movements in authorised, issued or treasury shares during the month.

Authorised capital stood unchanged at 5.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to USD 50,000 in total authorised share capital.

Issued share capital also remained static: 1.32 billion ordinary shares were in issue at both the beginning and end of September. The company held no treasury shares, and there were no share issuances, cancellations, or repurchases throughout the month.

Bayzed Health confirmed that it satisfies the Main Board’s minimum public float requirement, maintaining at least 25 % of issued shares in public hands as at month-end.

The Post-IPO Share Option Scheme, adopted on 8 August 2023 and amended on 9 June 2025, recorded no outstanding options and generated no new shares or proceeds in September. In addition, the issuer reported no warrants, convertible securities, or other share-linked instruments outstanding.

The filing was signed by Executive Director Chen Haoyang, who affirmed that all regulatory and listing rule obligations related to the company’s share capital were duly met during the reporting period.